Regen BioPharma Inc (RGBP)

[Schuller]

That was a fantastic 8K on Friday.

As far as I'm hearing the 50M raise is about done.

Regen needed about 20M to get their lead NR2F6 antagonist to phase 1 clinical so just imagine what can be done now with their whole IP.

Also Universities do not release their lab work for commercialization until it works, that's when it's valuable. The science that Regen will acquire in Canary is groundbreaking. Basically Cornell figured out how to grow the human tissue (not animal) in their lab and introduce the cancer, tumor etc then figure out the treatment to kill it before a patient ever started treatment the physicians would know how to treat it. Brilliant!

Regen and Koos got lucky here with their association with Lander and Cornell. This is now organically bigger that I imagined with this company.

I suspect the drop Friday was investors who wanted a quick buyout realizing that was not happening. Ironically Regen will become a much bigger buyout target down the road.

Cornell's science is groundbreaking. This is the type of science the news media latches onto. I would also expect to be read this essay in journals soon but now it will have Regen's name attached.

Good luck
Schuller